Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA study by Solbu, MD, Mjøen, G, Mark, PB, Holdaas, H, Fellström, B, Schmieder, RE, Zannad, F, Herrington, WG, Jardine, AG

A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease by Schlackow, I, Kent, S, Herrington, W, Emberson, J, Haynes, R, Reith, C, Wanner, C, Fellström, B, Gray, A, Landray, M, Baigent, C, Mihaylova, B

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation by Storey, B, Staplin, N, Haynes, R, Reith, C, Emberson, J, Herrington, W, Wheeler, D, Walker, R, Fellström, B, Wanner, C, Landray, M, Baigent, C

The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection. by Herrington, W, Emberson, J, Staplin, N, Blackwell, L, Fellström, B, Walker, R, Levin, A, Hooi, L, Massy, Z, Tesar, V, Reith, C, Haynes, R, Baigent, C, Landray, M

Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP) by Staplin, N, Haynes, R, Herrington, W, Reith, C, Cass, A, Fellström, B, Jiang, L, Kasiske, B, Krane, V, Levin, A, Walker, R, Wanner, C, Wheeler, D, Landray, M, Baigent, C, Emberson, J

Effects of lowering LDL cholesterol on progression of kidney disease. by Haynes, R, Lewis, D, Emberson, J, Reith, C, Agodoa, L, Cass, A, Craig, J, de Zeeuw, D, Feldt-Rasmussen, B, Fellström, B, Levin, A, Wheeler, D, Walker, R, Herrington, W, Baigent, C, Landray, M

Smoking and adverse outcomes in patients With CKD: the Study of Heart and Renal Protection (SHARP) by Emberson, J, Staplin, N, Haynes, R, Herrington, W, Reith, C, Landray, M, Baigent, C, Cass, A, Fellström, B, Jiang, L, Kasiske, B, Krane, V, Levin, A, Walker, R, Wanner, C, Wheeler, D, SHARP Collaborative Group

Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection. by Mafham, M, Staplin, N, Emberson, J, Haynes, R, Herrington, W, Reith, C, Wanner, C, Walker, R, Cass, A, Levin, A, Fellström, B, Jiang, L, Holdaas, H, Kasiske, B, Wheeler, D, Landray, M, Baigent, C, SHARP Collaborative Group

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controll... by Baigent, C, Landray, M, Reith, C, Emberson, J, Wheeler, D, Tomson, C, Wanner, C, Krane, V, Cass, A, Craig, J, Neal, B, Jiang, L, Hooi, L, Levin, A, Agodoa, L, Gaziano, M, Kasiske, B, Walker, R, Massy, Z, Feldt-Rasmussen, B, Krairittichai, U, Ophascharoensuk, V, Fellström, B, Holdaas, H, Tesar, V

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controll... by Baigent, C, Landray, M, Reith, C, Emberson, J, Wheeler, D, Tomson, C, Wanner, C, Krane, V, Cass, A, Craig, J, Neal, B, Jiang, L, Hooi, L, Levin, A, Agodoa, L, Gaziano, M, Kasiske, B, Walker, R, Massy, Z, Feldt-Rasmussen, B, Krairittichai, U, Ophascharoensuk, V, Fellström, B, Holdaas, H, Tesar, V